Genemed Synthesis Inc San Antonio, TX - 78244

Genemed Synthesis Inc is categorized under Enzyme and Isoenzyme Diagnostic Agents in San Antonio, TX and active since 2007.

Genemed Synthesis Inc was established in 2007, and today employs 1 to 4, earning Unknown per year. This is a Enzyme and Isoenzyme Diagnostic Agents business, which does work in the B2B market, and is classified as a Enzyme and Isoenzyme Diagnostic Agents, under code number 5417114 by the NAICS.

If you are seeking more information, feel free to contact Zainab Hassan, Administrator at the company’s single location by writing to 6203 Woodlake Center, San Antonio, Texas TX 78244 or by phoning (210) 745-5988. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Genemed Synthesis Inc
Contact Person: Zainab Hassan, Administrator
Address: 6203 Woodlake Center, San Antonio, Texas 78244
Phone Number: (210) 745-5988
Website Address: genemedsyn.com
Annual Revenue (USD): Unknown
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Enzyme and Isoenzyme Diagnostic Agents
SIC Code: 2835
NAICS Code: 5417114
Share This Business:

Genemed Synthesis Inc was started in 2007 to provide professional Enzyme and Isoenzyme Diagnostic Agents under the SIC code 2835 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Zainab Hassan, Administrator for inquiries that concern Genemed Synthesis Inc by calling the company number (210) 745-5988, as your correspondence is most welcome. Additionally, the physical location of the single location of Genemed Synthesis Inc can be found at the coordinates 29.4851,-98.35946 as well as the street address 6203 Woodlake Center in San Antonio, Texas 78244.

For its online presence, you may visit Genemed Synthesis Inc’s website at genemedsyn.com and engage with its social media outlets through on Twitter and on Facebook.